Best Near-Term Price Gains Ahead For: Newer, Developing Biotechnology Stocks


Market-makers [MMs] hedge their clients' trades in these stocks every day, protecting their firm's capital temporarily put at risk filling large volume trade orders. That price-change insurance tells just how far the MMs expect those clients, who have the money muscle to make things happen, to push prices - both up and down.



from Biotech News